{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:52:27Z","timestamp":1777467147198,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ek0109259"],"award-info":[{"award-number":["JP19ek0109259"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20ek0109474"],"award-info":[{"award-number":["JP20ek0109474"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ek0109474"],"award-info":[{"award-number":["JP21ek0109474"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["2\u20134"],"award-info":[{"award-number":["2\u20134"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jns.2021.117511","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T12:32:49Z","timestamp":1622118769000},"page":"117511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Metabolic complications in myotonic dystrophy type 1: A cross-sectional survey using the National Registry of Japan"],"prefix":"10.1016","volume":"427","author":[{"given":"Manami","family":"Hama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riho","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumasa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori P.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2021.117511_bb0005","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.117511_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20301","article-title":"Clinical and molecular aspects of the myotonic dystrophies: a review","volume":"32","author":"Machuca-Tzili","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.117511_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jns.2021.117511_bb0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2008.08.037","article-title":"A cross-sectional study for glucose intolerance of myotonic dystrophy","volume":"276","author":"Matsumura","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.117511_bb0025","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archneur.63.8.1149","article-title":"Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1","volume":"63","author":"Heatwole","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.117511_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.24540","article-title":"Metabolic syndrome in patients with myotonic dystrophy type 1","volume":"52","author":"Vujnic","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.117511_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/mus.21484","article-title":"Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy","volume":"41","author":"Shieh","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.117511_bb0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1600-0676.1989.tb00411.x","article-title":"Perisinusoidal cells (Ito-cells) enlargement in a family with myotonic dystrophy","volume":"9","author":"Poynard","year":"2008","journal-title":"Liver."},{"key":"10.1016\/j.jns.2021.117511_bb0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000292093","article-title":"Non-alcoholic steatohepatitis in myotonic dystrophy: DMPK gene mutation, insulin resistance and development of steatohepatitis","volume":"4","author":"Bhardwaj","year":"2010","journal-title":"Case Rep. Gastroenterol."},{"key":"10.1016\/j.jns.2021.117511_bb0050","first-page":"1633","article-title":"A case of liver cirrhosis due to non-alcoholic steatohepatitis complicated by myotonic dystrophy","volume":"110","author":"Ariake","year":"2013","journal-title":"J. Japanese Soc. Gastroenterol."},{"key":"10.1016\/j.jns.2021.117511_bb0055","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.jns.2021.117511_bb0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3949\/ccjm.87a.19078","article-title":"ACC\/AHA lipid guidelines: Personalized care to prevent cardiovascular disease","volume":"87","author":"Reiter-Brennan","year":"2020","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.jns.2021.117511_bb0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","article-title":"Consensus-based care recommendations for adults with myotonic dystrophy type 1","volume":"8","author":"Ashizawa","year":"2018","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jns.2021.117511_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-60","article-title":"Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy)","volume":"8","author":"Nakamura","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2021.117511_bb0075","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.nmd.2009.08.009","article-title":"Patient registries and trial readiness in myotonic dystrophy-TREAT-NMD\/Marigold International workshop report","volume":"19","author":"Thompson","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2021.117511_bb0080","first-page":"12","article-title":"Collaborating to bring new therapies to the patient - the TREAT-NMD model","volume":"28","author":"Bushby","year":"2009","journal-title":"Acta Myol."},{"key":"10.1016\/j.jns.2021.117511_bb0085","first-page":"325","article-title":"Dyslipidemia in special ethnic populations","volume":"33","author":"Pu","year":"2015","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.jns.2021.117511_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004836-199806000-00016","article-title":"Abnormal liver test results in myotonic dystrophy","volume":"26","author":"Achiron","year":"1998","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jns.2021.117511_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0954-6820.1987.tb10669.x","article-title":"Increased activity of serum \u03b3-Glutamyltransferase in myotonic dystrophy","volume":"222","author":"R\u00d6NNEMAA","year":"1987","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.jns.2021.117511_bb0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fneur.2020.00394","article-title":"High prevalence and gender-related differences of gastrointestinal manifestations in a cohort of DM1 patients: a perspective, cross-sectional study","volume":"11","author":"Perna","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2021.117511_bb0105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.jns.2021.117511_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jgh3.12070","article-title":"Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications","volume":"2","author":"Wong","year":"2018","journal-title":"JGH Open."},{"key":"10.1016\/j.jns.2021.117511_bb0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.10.9.705","article-title":"Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver","volume":"10","author":"Bouchier","year":"1969","journal-title":"Gut."},{"key":"10.1016\/j.jns.2021.117511_bb0120","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cca.2010.08.003","article-title":"Invited critical review triglycerides and gallstone formation","volume":"411","author":"Smelt","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jns.2021.117511_bb0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.atherosclerosis.2009.09.012","article-title":"Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study","volume":"209","author":"Okamura","year":"2010","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.jns.2021.117511_bb0130","series-title":"Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese","author":"Teramoto","year":"2007"},{"key":"10.1016\/j.jns.2021.117511_bb0135","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Cleeman","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jns.2021.117511_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.85.1.37","article-title":"Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study","volume":"85","author":"Manninen","year":"1992","journal-title":"Implic. Treatm. Circ."},{"key":"10.1016\/j.jns.2021.117511_bb0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21767\/2380-7245.100048","article-title":"Characteristics of risk-factor profiles associated with stroke in patients with myotonic dystrophy type 1","volume":"2","author":"Sugie","year":"2016","journal-title":"J. Rare Disord. Diagnosis Ther."},{"key":"10.1016\/j.jns.2021.117511_bb0150","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jns.2021.117511_bb0155","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.2174\/1381612811319290006","article-title":"From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights","volume":"19","author":"De Minicis","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jns.2021.117511_bb0160","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2018.04.023","article-title":"Treatment of dyslipidemia in common liver diseases","volume":"16","author":"Speliotes","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jns.2021.117511_bb0165","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2021.117511_bb0170","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2021.117511_bb0175","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1161\/CIRCULATIONAHA.114.013189","article-title":"Statin intolerance","volume":"131","author":"Fitchett","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.jns.2021.117511_bb0180","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.bor.0000434673.85515.89","article-title":"The spectrum of statin myopathy","volume":"25","author":"Mohassel","year":"2013","journal-title":"Curr. Opin. Rheumatol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:55:59Z","timestamp":1758383759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21002057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":36,"alternative-id":["S0022510X21002057"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117511","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic complications in myotonic dystrophy type 1: A cross-sectional survey using the National Registry of Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117511"}}